Search Results - "SLAUGHTER, R. L"

Refine Results
  1. 1

    Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial by Vaezi, M F, Richter, J E, Wilcox, C M, Schroeder, P L, Birgisson, S, Slaughter, R L, Koehler, R E, Baker, M E

    Published in Gut (01-02-1999)
    “…Background Intrasphincteric injection of botulinum toxin is a new treatment option for achalasia. Aims To compare the immediate and long term efficacy of…”
    Get full text
    Journal Article
  2. 2

    Evaluation of dextrose 50 % as a medium for injection-assisted polypectomy by Varadarajulu, S, Tamhane, A, Slaughter, R L

    Published in Endoscopy (01-09-2006)
    “…Injection-assisted polypectomy (IAP) is traditionally carried out by using normal saline as the submucosal fluid cushion. However, normal saline, being…”
    Get more information
    Journal Article
  3. 3

    Recent advances: the cytochrome P450 enzymes by Slaughter, R L, Edwards, D J

    Published in The Annals of pharmacotherapy (01-06-1995)
    “…Successful application of information on cytochrome P450 to prevent drug interactions and improve the therapeutic risk: benefit ratio can occur only if we know…”
    Get more information
    Journal Article
  4. 4

    Treatment of achalasia: the best of both worlds by Abid, S, Champion, G, Richter, J E, McElvein, R, Slaughter, R L, Koehler, R E

    Published in The American journal of gastroenterology (01-07-1994)
    “…To conduct a retrospective analysis of one center's experience with treating achalasia over 4 yr with skilled gastroenterologists using primarily the Rigiflex…”
    Get more information
    Journal Article
  5. 5

    Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight by Ducharme, M P, Slaughter, R L, Edwards, D J

    Published in Therapeutic drug monitoring (01-10-1994)
    “…The effects of age, gender, and body weight on the pharmacokinetics of vancomycin were examined using data collected as part of routine therapeutic drug…”
    Get more information
    Journal Article
  6. 6

    Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin by Ducharme, M P, Slaughter, R L, Warbasse, L H, Chandrasekar, P H, Van de Velde, V, Mannens, G, Edwards, D J

    Published in Clinical pharmacology and therapeutics (01-12-1995)
    “…To study the disposition of single doses of phenytoin and itraconazole when administered alone and after chronic treatment with the other drug. Healthy male…”
    Get more information
    Journal Article
  7. 7

    Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM by JABER, L. A, ANTAL, E. J, SLAUGHTER, R. L, WELSHMAN, I. R

    Published in Diabetes care (01-11-1994)
    “…Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM. L A Jaber , E J Antal , R L Slaughter and I R Welshman…”
    Get full text
    Journal Article
  8. 8

    Clinical interventions provided by doctor of pharmacy students by Slaughter, R L, Erickson, S R, Thomson, P A

    Published in The Annals of pharmacotherapy (01-05-1994)
    “…To assess the types, perceived benefit, and cost impact of the interactions provided by two-year post-B.S. Pharm.D. students on clerkship rotations…”
    Get more information
    Journal Article
  9. 9

    The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics by JABER, L. A, ANTAL, E. J, SLAUGHTER, R. L, WELSHMAN, I. R

    Published in European journal of clinical pharmacology (01-12-1993)
    “…We have studied the pharmacokinetics and pharmacodynamics of glyburide during long-term therapy in 20 patients with type II diabetes mellitus. The patients…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity by Dunn, T E, Ludwig, E A, Slaughter, R L, Camara, D S, Jusko, W J

    Published in Clinical pharmacology and therapeutics (01-05-1991)
    “…Methylprednisolone pharmacokinetics and its directly suppressive effects on plasma cortisol, blood histamine (basophils), and circulating helper T cells were…”
    Get more information
    Journal Article
  11. 11

    Diabetes and related metabolic risk factors among Arab Americans by Jaber, L A, Slaughter, R L, Grunberger, G

    Published in The Annals of pharmacotherapy (01-06-1995)
    “…To estimate the incidence of noninsulin-dependent diabetes mellitus (NIDDM) and associated metabolic abnormalities such as impaired glucose tolerance,…”
    Get more information
    Journal Article
  12. 12

    Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy by Cimino, M A, Rotstein, C, Slaughter, R L, Emrich, L J

    Published in The American journal of medicine (01-12-1987)
    “…Methicillin-resistant coagulase-negative staphylococci have become increasingly responsible for febrile episodes in cancer patients, often necessitating the…”
    Get more information
    Journal Article
  13. 13

    The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy by Jaber, L A, Lewis, N J, Slaughter, R L, Neale, A V

    Published in Journal of clinical pharmacology (01-03-1993)
    “…Stress adversely affects glycemic control in patients with type II diabetes mellitus. In addition, stress reduction with relaxation techniques or medication…”
    Get more information
    Journal Article
  14. 14

    Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects by Kong, A N, Ludwig, E A, Slaughter, R L, DiStefano, P M, DeMasi, J, Middleton, Jr, E, Jusko, W J

    Published in Clinical pharmacology and therapeutics (01-12-1989)
    “…Pharmacodynamic models for "directly suppressive" effects of methylprednisolone are based on the premise that receptor interactions of steroids are followed by…”
    Get more information
    Journal Article
  15. 15

    Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion by Glynn, A M, Slaughter, R L, Brass, C, D'Ambrosio, R, Jusko, W J

    Published in Clinical pharmacology and therapeutics (01-06-1986)
    “…The disposition of methylprednisolone was examined in six normal subjects after the injection of 20 mg iv methylprednisolone sodium succinate. Disposition…”
    Get more information
    Journal Article
  16. 16

    Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis by Pollack, G M, Buchanan, J F, Slaughter, R L, Kohli, R K, Shen, D D

    Published in Toxicology and applied pharmacology (30-06-1985)
    “…The degree of exposure to the plasticizer di(2-ethylhexyl) phthalate (DEHP) was assessed in 11 patients undergoing maintenance hemodialysis for the treatment…”
    Get more information
    Journal Article
  17. 17

    Probability assessment approach to therapeutic drug monitoring: tobramycin by Slaughter, R L

    Published in DICP (Cincinnati, Ohio) (01-03-1989)
    “…Pharmacokinetic monitoring is an important therapeutic goal of aminoglycoside therapy. The overall goal of this study was to identify specific patient groups…”
    Get more information
    Journal Article
  18. 18

    Intrasubject variability of theophylline clearance in a morbidly obese patient by Slaughter, R L, Nairn, D

    Published in Drug intelligence & clinical pharmacy (01-11-1986)
    “…It is well appreciated that theophylline pharmacokinetics exhibits wide intersubject variation. Within-subject changes in clearance have been generally…”
    Get more information
    Journal Article
  19. 19

    Comparison of assay procedures used to measure total and unbound concentrations of quinidine by Wooding-Scott, R A, Darling, I M, Slaughter, R L

    Published in DICP (Cincinnati, Ohio) (01-12-1989)
    “…Individualized quinidine dosing through the assessment of serum concentrations is warranted because of the wide variability observed in its pharmacokinetic…”
    Get more information
    Journal Article
  20. 20

    Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogs by Baxter, J G, Brass, C, Schentag, J J, Slaughter, R L

    Published in Journal of pharmaceutical sciences (01-05-1986)
    “…The single-dose pharmacokinetics and bioavailability of three ketoconazole formulations were evaluated using HPLC in five healthy human volunteers and six male…”
    Get more information
    Journal Article